News and Trends 23 Jun 2015
Chris Viehbacher to run Swiss billionaire’s investment fund
One of our favorite bio-celebrities is enlarging his CV with a new job position. The German-Canadian Chris Viehbacher will run…
Lourdes Riquelme
About
Spanish Biotechnologist with a MS in Genetics from Universidad Autonoma of Barcelona. My interests go from science to fashion and anything in between.Articles by Lourdes Riquelme
News and Trends 23 Jun 2015
Will Boehringer Ingelheim win the race for anticoagulants?
Boehringer Ingelheim has released the last figures of its idarucizumab Phase III. The breakthrough anti-anticoagulant is being studied as an…
News and Trends 22 Jun 2015
Kamada and Baxter extend their collaboration in Lung Transplant
The Israeli biotech Kamada and Baxalta, Baxter’ subsidiary will jointly co-fund a trial test to find out whether Kamada’s candidate is capable…
News and Trends 22 Jun 2015
Medigene plans to fund its T-cell program with €50 Millions
Munich-based Medigene is planning to raise cash through existing shareholders’ investments. The company targets up to €50M to propel its…
ADVERTISEMENT
News and Trends 19 Jun 2015
Celyad, the new face of Cardio3, is launching an IPO on NASDAQ
[UPDATE 19/06/2015]: Yesterday, Celyad launched its IPO on NASDAQ and the closing is expected to occur on 24 June 2015. Celyad,…
News and Trends 19 Jun 2015
Servier disburses €114 Million for Taiho’s Colorectal Cancer treatment
Servier is fattening up its oncology assests with the acquisition of Taiho Pharmaceutical’s treatment of refractory mestatic colorectal cancer. The…
News and Trends 17 Jun 2015
Innovate UK accelerates Sareum’s fight against Leukemia
Innovate UK, the country’s innovation agency, keeps promoting technology in the British islands. The latest beneficiary is Sareum, a cancer…
News and Trends 16 Jun 2015
Bayer set a strategic alliance with J. Hopkins in retinal diseases
Bayer HealthCare and the Johns Hopkins University in Baltimore have entered into a five-year collaboration to develop ophthalmic therapies. The…
News and Trends 15 Jun 2015
GSK’s undercover incubator baked three new Biotechs
The partnership between GlaxoSmithKline and Avalon Ventures launched three early-stage life science companies. Adrenergics, CadheRx Therapeutics and Calporta Therapeutics will…
News and Trends 15 Jun 2015
Jonhson&Jonhson hurries up Genmab’s myeloma treatment
Genmab and its partner Jonhson&Jonhson, through its subsidiary Janssen Biotech, are trying to speed up daratumumab. The companies initiated a…
ADVERTISEMENT
News and Trends 12 Jun 2015
The first-in-human proof that Epigenetics marks are transmitted to the offspring
If a father works out every night and day at the gym, will he have a brawny baby? Well, yes…
News and Trends 12 Jun 2015
MRC Technology and Peptinnovate partnered to cure bone diseases
MRC Technology and Peptinnovate teamed up to target bone diseases using peptides derived from the bacterium Mycobacterium tuberculosis. The partnership…
News and Trends 12 Jun 2015
Polaris, a new Nordic leader in Immuno-Oncology
Immuno-oncology is a busy market to take on by yourself due to the existing fierce competition. Targovax and Oncos Therapeutics have decided…
News and Trends 11 Jun 2015
Cosmo’s dermatology spin-out Cassiopea IPOes before the end of its Phase III
Cassiopea, Cosmo Pharmaceutical’s spin-out, will be listed on the Swiss Stock Exchange. Cosmo Pharmaceutical plans to reduce its current 97%…
News and Trends 11 Jun 2015
Pieris Pharma: is it worth going to NASDAQ for only €31 Million?
Pieris Pharmaceutical is planning to raise €31M in an surprisingly low US IPO. The company seeks to advance its early-stage…
News and Trends 11 Jun 2015
Pharmas step on the gas chasing the next blockbuster in Type 2 Diabetes
Hundreds of millions of people all over the word suffer from type 2 Diabetes and the competition between pharma companies…
ADVERTISEMENT
News and Trends 10 Jun 2015
French collaboration to develop Oncology-targeted Therapy
PEP-Therapy and CleveXel Pharma will co-develop targeted therapy in oncology. The product is based on an innovative technology involving bi-functional…
News and Trends 9 Jun 2015
Novozymes to construct a new R&D campus in Denmark
Novozymes will build a new campus dedicated to research and business development in Denmark, in the north of Copenhagen. With…
News and Trends 9 Jun 2015
Apitope’s peptide to take on Haemophilia A
Apitope’s pre-clinical candidate ATX-F8-117 has been granted Orphan Drug Status by the US FDA for the treatment of Haemophilia A.…
News and Trends 8 Jun 2015
Biosimilars will land in Poland thanks to a European loan
Biosimilars will have their Polish guarantor. Polpharma, the largest Polish producer of medicines, is the first benefactor of a €45M…